| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 66,309 | 81,283 | 77,202 | 87,548 | | Cost of Revenue | 29,539 | 35,296 | 32,784 | 38,857 | | | Gross Profit | 36,770 | 45,987 | 44,418 | 48,691 | | | Operating Expenses | | Research Development | 13,610 | 13,719 | 13,928 | 13,924 | | Selling General and Administrative | 28,843 | 30,504 | 31,261 | 33,187 | | Non Recurring | (513) | 153 | 2,092 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,170) | 1,611 | (2,863) | 1,580 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 163 | (117) | 1,083 | 1,638 | | Earnings Before Interest And Taxes | (5,007) | 1,494 | (1,780) | 3,218 | | Interest Expense | 39 | 55 | 23 | 19 | | Income Before Tax | (5,046) | 1,439 | (1,803) | 3,199 | | Income Tax Expense | 436 | 555 | 371 | 733 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,482) | 884 | (2,174) | 2,466 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,482) | 884 | (2,174) | 2,466 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,482) | $884 | ($2,174) | $2,466 |
|
0.51% Nasdaq 
Income Statement
